Molecular Docking Analysis of Zerumbone Derivatives as XIAP-BIR3 Inhibitor for Anticancer Agent. nuscientech [Internet]. 2024 Dec. 4 [cited 2025 Apr. 25];2024(46):8-14. Available from: https://nstproceeding.com/index.php/nuscientech/article/view/1292